Research: GHALAUT, SINGH and GUP

Listed in Issue 57

Abstract

GHALAUT, SINGH and GUPTA, Dept of Medicine (Unit-VI) and Haematology, Pt BD Sharma Post Graduate Institute of Medical Sciences, Rohtak set out to investigate Serum vitamin E levels in patients of chronic myeloid leukaemia.

Background

To estimate vitamin E levels in sera of patients of chronic myeloid leukaemia (CML) before and after treatment with busulphan and hydroxyurea and to compare the levels with those in healthy controls.

Methodology

The study of 50 subjects (mean age 34 ±8.86 years), 25 of which were proved cases of chronic myeloid leukaemia (CML) and 25 were healthy controls. Vitamin E level was measured by spectrofluorometric method. In patients of CML, vitamin E level was estimated twice. Once when their total leucocyte count (TLC) was raised (i.e. before treatment) and then after treatment after bringing the TLC near normal.

Results

The mean serum vitamin E level in 25 normal healthy controls was 7.19 mcg/ml and that in 25 patients of CML at presentation (before treatment) was 2.67 mcg/ml. It increased to 3.61 mcg/ml after treatment.

Conclusion

The results show that patients of CML have a significantly lower (p < 0.001) level of serum vitamin E as compared to normal healthy adults and that the level of vitamin E increased significantly (p < 0.001) after treatment even without supplementing vitamin E.

References

Ghalaut PS et al. Serum vitamin E levels in patients of chronic myeloid leukaemia. Journal of Association of Physicians of India 47(7): 703-4. Jul 1999.

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page